Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT06712602 · ClinicalTrials.gov registry record · Phase 1

PT150 Drug for Use in Alcohol Use Disorder

A Phase 1 study of Alcohol Use Disorder, sponsored by Pop Test Oncology.

Recruiting
Registry status
Phase 1
Development phase
34
Enrollment target
1
Study location

NCT06712602 is a Phase 1 study of Alcohol Use Disorder that is actively recruiting participants, run by Pop Test Oncology. The registered enrollment target is 34 participants, below the 328-participant average among 184 other Alcohol Use Disorder trials with a reported enrollment target (90% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT06712602, a Phase 1 study of Alcohol Use Disorder, is actively recruiting participants, sponsored by Pop Test Oncology.

RECRUITING
Registry status
Phase 1
Development phase
34 participants
Enrollment target
1
Study location

Study Summary

The goal of this study is to learn if PT150 can reduce the behavioral and physical effects of stress, alcohol, and alcohol use in people with alcohol use disorder.

Conditions Studied

Alcohol Use Disorder

Interventions

  • DRUG alcohol
  • BEHAVIORAL Stress-Induction
  • DRUG PT150

Study Locations (1)

Kentucky

  • University of Kentucky - Lexington

Trial Details

FieldValue
Enrollment Target 34 participants
Start Date 2025-02-01
Est. Completion 2028-07-31
Phase Phase 1

Sponsor

Pop Test Oncology

3 total trials

Interested in This Trial?

Full Details on ClinicalTrials.gov ↗

What the Registry Record Tells You About NCT06712602

The ClinicalTrials.gov registry entry for NCT06712602 describes a study currently listed as recruiting, categorized as Phase 1. The registered enrollment target is 34 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 328-participant average among 184 other Alcohol Use Disorder trials with a reported enrollment target (90% lower). The listed sponsor is Pop Test Oncology, which has 3 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Alcohol Use Disorder appearing as the primary indexed condition, and to 3 interventions - of which alcohol is the first listed.

NCT06712602 reports 1 study location spanning 1 distinct geographic area - top geographies include Kentucky.

Frequently Asked Questions

What is clinical trial NCT06712602 about?

NCT06712602 is a clinical study titled "PT150 Drug for Use in Alcohol Use Disorder". The goal of this study is to learn if PT150 can reduce the behavioral and physical effects of stress, alcohol, and alcohol use in people with alcohol use disorder.

What is the current status of trial NCT06712602?

This trial is currently recruiting. It is a Phase 1 study. The enrollment target is 34 participants. The study started on 2025-02-01. Estimated completion is 2028-07-31.

What conditions does trial NCT06712602 study?

This clinical trial studies the following conditions: Alcohol Use Disorder.

What interventions are being tested in trial NCT06712602?

The interventions under investigation include: alcohol (DRUG), Stress-Induction (BEHAVIORAL), PT150 (DRUG).

Who is sponsoring clinical trial NCT06712602?

This trial is sponsored by Pop Test Oncology, which has 3 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT06712602 being conducted?

This trial has 1 study location across Kentucky. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Learn More About Clinical Trials

Similar trials for Alcohol Use Disorder

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Explore more on PlainTrial

Alcohol Use Disorder

All registered trials for this condition

Kentucky

All trials with a study site in Kentucky

Recruiting now

Find trials open to new participants near you

Rankings

Top sponsors, conditions, and phases

Read our methodology - how this data is sourced, computed, and verified.

Related

Browse all → | Rankings →
Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.